- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x IBI: N-{trans-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}-4-{[(7R)-7-ethyl-5-methyl-8-(1-methylethyl)-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxybenzamide(Non-covalent)
- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 4 residues within 4Å:- Chain A: R.125, R.126, E.130, L.309
1 PLIP interactions:1 interactions with chain A- Water bridges: A:L.131
EDO.3: 6 residues within 4Å:- Chain A: K.168, G.170, N.171, D.184
- Ligands: IBI.1, GOL.10
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.168, A:K.168
EDO.5: 4 residues within 4Å:- Chain A: H.100, L.152, Q.155, Y.156
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.152, A:Q.155, A:Y.156
EDO.7: 3 residues within 4Å:- Chain A: N.206, Y.207, P.239
No protein-ligand interaction detected (PLIP)EDO.12: 4 residues within 4Å:- Chain B: R.125, R.126, E.130, L.309
1 PLIP interactions:1 interactions with chain B- Water bridges: B:L.131
EDO.13: 6 residues within 4Å:- Chain B: K.168, G.170, N.171, D.184
- Ligands: IBI.11, GOL.20
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:K.168, B:K.168, B:D.184
EDO.15: 4 residues within 4Å:- Chain B: H.100, L.152, Q.155, Y.156
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.152, B:Q.155, B:Y.156
EDO.17: 3 residues within 4Å:- Chain B: N.206, Y.207, P.239
No protein-ligand interaction detected (PLIP)- 4 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 4 residues within 4Å:- Chain A: F.54, K.72, M.88, E.91
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:F.54, A:E.91
- Salt bridges: A:K.72
ACT.8: 7 residues within 4Å:- Chain A: H.83, Q.84, K.87, C.202
- Chain B: C.245, L.246
- Ligands: ZN.9
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:Q.84, B:L.246
- Salt bridges: A:H.83, A:K.87
- Hydrophobic interactions: B:L.246
ACT.14: 4 residues within 4Å:- Chain B: F.54, K.72, M.88, E.91
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:F.54, B:E.91
- Salt bridges: B:K.72
ACT.18: 7 residues within 4Å:- Chain A: C.245, L.246
- Chain B: H.83, Q.84, K.87, C.202
- Ligands: ZN.19
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:Q.84, A:L.246
- Salt bridges: B:H.83, B:K.87
- Hydrophobic interactions: A:L.246
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x ZN: ZINC ION(Non-covalent)
ZN.9: 6 residues within 4Å:- Chain A: H.83, K.87, C.202
- Chain B: C.245, L.246
- Ligands: ACT.8
4 PLIP interactions:2 interactions with chain A, 1 interactions with chain B, 1 Ligand-Ligand interactions- Metal complexes: A:H.83, A:C.202, B:C.245, ACT.8
ZN.19: 6 residues within 4Å:- Chain A: C.245, L.246
- Chain B: H.83, K.87, C.202
- Ligands: ACT.18
4 PLIP interactions:2 interactions with chain B, 1 interactions with chain A, 1 Ligand-Ligand interactions- Metal complexes: B:H.83, B:C.202, A:C.245, ACT.18
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.10: 7 residues within 4Å:- Chain A: R.126, S.127, E.130, G.170, F.173
- Ligands: IBI.1, EDO.3
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.126, A:R.126, A:G.170
GOL.20: 7 residues within 4Å:- Chain B: R.126, S.127, E.130, G.170, F.173
- Ligands: IBI.11, EDO.13
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.126, B:R.126, B:G.170
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rudolph, D. et al., BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity. Clin.Cancer Res. (2009)
- Release Date
- 2009-05-12
- Peptides
- Serine/threonine-protein kinase PLK1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.45 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x IBI: N-{trans-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}-4-{[(7R)-7-ethyl-5-methyl-8-(1-methylethyl)-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxybenzamide(Non-covalent)
- 8 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x ACT: ACETATE ION(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x ZN: ZINC ION(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rudolph, D. et al., BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity. Clin.Cancer Res. (2009)
- Release Date
- 2009-05-12
- Peptides
- Serine/threonine-protein kinase PLK1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A